Eribulin Provides a Remarkable Effect in Trabectedin-Resistant Myxoid Liposarcoma

Adriamycin-based chemotherapy is commonly used for malignant soft tissue sarcoma including myxoid liposarcoma. However, in the case of unavailability or failure of the adriamycin-based regimen, trabectedin or eribulin can produce a good antitumor effect for myxoid liposarcoma. We relate the experien...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamiya, Hironari, Sabe, Hideaki, Yamashita, Katsunari, Imura, Yoshinori, Wakamatsu, Toru, Takenaka, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683141/
https://www.ncbi.nlm.nih.gov/pubmed/33274094
http://dx.doi.org/10.1155/2020/8873185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683141/
https://www.ncbi.nlm.nih.gov/pubmed/33274094
http://dx.doi.org/10.1155/2020/8873185

Ejemplares similares